Brad practises complex patent litigation, including pharmaceutical proceedings under PM(NOC) Regulations. He provides strategic advice on the enforcement of patent rights and coordination and management of litigation strategies throughout multiple jurisdictions. He has appeared as lead counsel before the Federal Court of Appeal, Federal Court, Superior Court of Ontario, and as worldwide coordinating litigation and IP counsel before the European Patent Office and the US International Trade Commission. A Registered Patent Agent, Brad specializes in Canadian and foreign patent and industrial design prosecution, strategic IP portfolio reviews, patentability, patent infringement and validity opinions, worldwide patent portfolio management, and enforcement advice. Key clients include Teva Canada, Mylan Pharmaceuticals, Samsung Bioepis, and Pharmascience Inc. Brad is a frequent author in global publications including IAM and Managing Intellectual Property. He co-author of the Canadian Intellectual Property Guide 2018 published by the Chinese National Intellectual Property Administration (CNIPA, formerly SIPO).